Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling.
Zheng Q, Martin RC, Shi X, Pandit H, Yu Y, Liu X, Guo W, Tan M, Bai O, Meng X, Li Y.
Zheng Q, et al. Among authors: li y.
Theranostics. 2020 Aug 7;10(22):9923-9936. doi: 10.7150/thno.45988. eCollection 2020.
Theranostics. 2020.
PMID: 32929325
Free PMC article.